Equine Performance Labs (EPL), the team behind equicenta® CTM — announced the publication of a peer-reviewed, prospective, ...
The SMARTFLOW™ clinical team at the Minneapolis Heart Institute Foundation (MHIF) at Allina Health Minneapolis Heart ...
Obsidian Therapeutics, Inc. ("Obsidian") (Nasdaq: OBX), a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte ...
Delray Medical Center says new MRI-guided focused ultrasound offers effective, incisionless treatment for Parkinson’s motor ...
5h
Study identifies care steps that start head and neck cancer patients on lifesaving treatment sooner
For patients with advanced head and neck cancer, surgery is often the first step in treatment. Many also need radiation ...
Vietnam Investment Review on MSN
Innovent doses first patient in pivotal colorectal cancer study
SAN FRANCISCO and SUZHOU, China, Aug. 6, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and ...
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and ...
You’ve likely heard that high LDL cholesterol (or the so-called “bad” cholesterol) is a major risk factor for heart disease.
A study on 'Nexpowder', NextBioMedical's endoscopic wound covering material, has been published in an international academic journal. According to Ne ...
Shionogi & Co (SGIOF) announced an update on their ongoing clinical study.
Milestone reflects continued execution of the Company's pivotal U.S. clinical study evaluating EndoZip™ for Endoscopic Sleeve Gastroplasty CAESAREA, Israel, July 28, 2026 /PRNewswire/ -- Nitinotes Ltd ...
An Italian study found microplastics in the blood of most heart attack patients, but its small size keeps the finding far ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results